Y. Arai
发表
Y. Arai,
A. Fujimori,
K. Sudoh,
2007,
Current opinion in pharmacology.
Y. Arai,
J. Tsukada,
A. Tahara,
2002,
Pharmacological research.
Y. Arai,
K. Sudoh,
T. Takenaka,
1998,
General pharmacology.
Y. Arai,
A. Fujimori,
K. Sudoh,
2005,
European journal of pharmacology.
Y. Arai,
J. Tsukada,
A. Tahara,
2002,
European journal of pharmacology.
Y. Arai,
A. Fujimori,
M. Sasamata,
2009,
Journal of pharmacological sciences.
Y. Arai,
A. Fujimori,
K. Sudoh,
2007,
Biological & pharmaceutical bulletin.
Y. Arai,
Takafumi Nakamura,
Midori Yamashita,
2021,
Molecular therapy oncolytics.
Y. Arai,
T. Takenaka,
K. Honda,
1997,
European journal of pharmacology.
Effect of YM435, a dopamine DA1 receptor agonist, in a canine model of ischemic acute renal failure.
Y. Arai,
T. Takenaka,
A. Tanaka,
1998,
General pharmacology.
Y. Arai,
T. Takenaka,
W. Uchida,
1997,
General pharmacology.
Y. Arai,
Takafumi Nakamura,
Midori Yamashita,
2021,
Cancer Immunology, Immunotherapy.
Y. Arai,
T. Kawase,
Takafumi Nakamura,
2020,
Science Translational Medicine.
G. Shapiro,
P. LoRusso,
J. Infante,
2016,
Cancer Chemotherapy and Pharmacology.
A. Takeshita,
H. Ueno,
H. Shimokawa,
1995,
Circulation.
J. Oyama,
A. Takeshita,
H. Shimokawa,
1998,
The Journal of clinical investigation.
Y. Arai,
K. Miyata,
S. Nishijima,
2001,
Atherosclerosis.